
The 5 things you need to know before the stock market opens today: the White House is still working out the details of President Trump’s plan to charge 15% export taxes on chipmakers’ business in China, OpenAI’s Sam Altman is working on a Neuralink competitor, the FDA is considering revoking authorization for Pfizer's Covid-19 vaccine for healthy children under age 5, Circle announced a new stock offering and a U.S. base in Anchorage is preparing to host the upcoming Trump-Putin Alaska summit. Squawk Box is hosted by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Follow Squawk Pod for the best moments, interviews and analysis from our TV show in an audio-first format.
Loading summary
A
Golddealer.com provides one of the nation's largest inventories of gold, silver, platinum, palladium and rhodium bullion, and our website offers live buy and sell prices. We specialize in precious metal IRA accounts, charge no setup or shipping fees, and provide one of the best storage programs in the business. Golddealer.com also provides a free audio quote line that is updated twice each day and a gold newsletter that is published every week. This episode is brought to you by Schwab Market Update, an original podcast from Charles Schwab. Join host Keith Lansford for this information packed daily market Preview delivered in 10 minutes or less, including projected stock updates, monetary policy decisions and key results and statistics that may impact your trading. Download the latest episode and subscribe@schwab.com Market Update podcast or find Schwab Market Update wherever you get your podcasts. Hi, I'm Andrew Osorkin, co host of Squawkbox and this is five things to know before today's opening bell. The White House saying the Commerce Department still working out the legal details of President Trump's plan to charge 15% export taxes on Nvidia and AMD for sending certain semiconductors to China. The White House press secretary saying that similar arrangements could be applied to other companies in the future. The Financial Times reports that OpenAI CEO Sam Altman getting ready to back a company that will compete with Elon Musk's Neuralink. The FT says the company is called Merge Labs and is raising money at $850 million valuations, I should say evaluation and the FDA considering revoking its authorization of Pfizer's COVID 19 vaccine for healthy children under the age of five. Vaccines from Moderna and Nova Novavax are cleared for more limited populations and shares of Circle closing higher by 1.3% yesterday that after the company reported a 53% increase in revenue. But after the closing bell the company announced a new stock offering of 10 million shares, the stock now under pressure as a result this morning 2 million of those shares will be offered by circle. The remaining 8 million will be sold by stockholders and details emerging on the upcoming meeting in Alaska between President Trump and Russian President Vladimir Putin. A White House official telling NBC News that the Friday sit down will take place at Joint Base Eltendorf Richardson in Anchorage. So we're going to keep our eyes of course on that. We're going to be back later today with an all new squawkpod, our daily podcast featuring the best of Squawkbox. Check it out wherever you get your podcast and listen anytime. What made you confident that you could do something that hadn't been done before? I have no fear of failure. Trailblazing women, Changing the game One of my favorite pieces of advice Think about what your boss's boss needs. Leadership can look in many, many different forms. It really does come down to just trusting yourself. Life is short and you just gotta think big to accomplish big things. Julia Boorstin hosts CNBC Change Makers and Power Players New episodes every Tuesday. Wherever you get your podcasts.
Podcast: Squawk Pod
Host: CNBC
Episode Date: August 13, 2025
Summary Prepared By: Podcast Summarizer AI
This episode delivers a brisk rundown of the top market-moving headlines and business news for the day ahead, as curated from CNBC’s flagship morning show, Squawk Box, anchored by Andrew Ross Sorkin. The themes touch on global trade tensions, tech-innovation rivalries, public health policy shifts, notable company earnings, and diplomatic developments—aiming to equip listeners with the five most critical insights before Wall Street opens.
Quote:
"The White House saying the Commerce Department still working out the legal details of President Trump's plan to charge 15% export taxes on Nvidia and AMD for sending certain semiconductors to China."
— Andrew Ross Sorkin [00:25]
Quote:
"The FT says the company is called Merge Labs and is raising money at $850 million valuations, I should say evaluation..."
— Andrew Ross Sorkin [00:44]
Quote:
"The FDA considering revoking its authorization of Pfizer's COVID 19 vaccine for healthy children under the age of five..."
— Andrew Ross Sorkin [00:53]
Quote:
"The company reported a 53% increase in revenue. But after the closing bell the company announced a new stock offering of 10 million shares, the stock now under pressure as a result this morning..."
— Andrew Ross Sorkin [01:08]
Quote:
"Details emerging on the upcoming meeting in Alaska between President Trump and Russian President Vladimir Putin...the Friday sit down will take place at Joint Base Eltendorf Richardson in Anchorage."
— Andrew Ross Sorkin [01:22]
On Market Uncertainty:
"We're going to keep our eyes of course on that."
— Andrew Ross Sorkin [01:31]
The episode maintains a brisk, no-nonsense tone, staying tightly focused on actionable news for investors.
| Timestamp (MM:SS) | Segment | |-----------------------|--------------------------------------------------------------------| | 00:25 | Semiconductor export-tax plan and White House comments | | 00:44 | Sam Altman’s Merge Labs to rival Neuralink | | 00:53 | FDA reconsidering Pfizer COVID vaccine for children under 5 | | 01:08 | Circle’s earnings, revenue jump, and surprise stock offering | | 01:22 | Details of Trump-Putin Alaska summit | | 01:31 | Closing remarks and transition |
Listeners are left with a clear sense of the pivotal stories likely to move global markets—particularly watching U.S. semiconductor policy, biotech developments, and diplomatic summits. The host, Andrew Ross Sorkin, ensures that investors and market observers know where to focus their attention as the markets open.